Skip to main navigation
Skip to Content
Terns Pharmaceuticals
  • About Us
    • Leadership
    • Board of Directors
  • Our Approach
    • Our Approach
    • Scientific Publications
  • Pipeline
    • Pipeline
    • Our Programs
    • Expanded Access
  • Investors & Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Email Alerts
  • Partnerships
  • Careers

Press Releases

06.6.23
Terns Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference
06.2.23
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
05.25.23
Terns Pharmaceuticals Announces Publication of TERN-701 Trial-in-Progress Abstract for the 2023 ASCO Annual Meeting
05.24.23
Terns Pharmaceuticals to Present at Upcoming Investor Conferences
05.22.23
Terns Pharmaceuticals to Highlight New Preclinical Data for TERN-601 Program in Obesity at the American Diabetes Association’s 83rd Annual Scientific Sessions
05.15.23
Terns Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updates
05.9.23
Terns Pharmaceuticals to Participate in the JMP Securities 2023 Life Sciences Conference
05.3.23
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
03.27.23
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
03.27.23
Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as Chief Medical Officer of Terns Oncology

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Email Alerts
RSS Feeds
Print Page
Contact IR
Terns Logo
TERNS
1065 East Hillsdale Blvd., Suite 100
Foster City, CA 94404 (MAP)
info@ternspharma.com
investors@ternspharma.com
media@ternspharma.com
Phone: +1 650-525-5535 Ext.101
Fax: +1 650-275-4254
  • LinkedIn
  • Twitter
  • About Us
  • Our Approach
  • Pipeline
  • Investors & Media
  • Partnerships
  • Careers
  • Contact Us
© 2023 Terns Pharmaceuticals, Inc. Privacy Policy